Form 4 for SRTA Strata Critical Medical, Inc.
Accepted 2022-06-30 00:00:00 ET · period of report 2022-06-28 · accession 0001779128-22-000065 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-06-30 | 2022-06-28 | SRTA | Keene Brandon A. | Chief Innovation Off | M - OptEx | $0.18 | +150.0K | 399.9K | +60% | +$27.0K |
| D | 2022-06-30 | 2022-06-28 | SRTA | Keene Brandon A. | Chief Innovation Off | M - OptEx | $0.00 | -150.0K | 36.3K | -81% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A common stock, $0.0001 par value per share | 2022-06-28 | M | A | 150,000 | $0.18 | 399,879 | D | — | — | |
| 2 | Derivative | Stock Option (right to buy) | 2022-06-28 | M | D | 150,000 | $0.00 | 36,331 | D | $0.18 · 2021-05-07 to 2027-06-27 | 150,000 Class A common stock, $0.0001 par value per share |